dapivirine gel (0.05%)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for dapivirine gel (0.05%), covering 2019-11-07 to 2019-11-07. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults [Phase 1]